首页> 外文期刊>British journal of ophthalmology >A reappraisal of cryosurgery for eyelid basal cell carcinomas.
【24h】

A reappraisal of cryosurgery for eyelid basal cell carcinomas.

机译:对眼睑基底细胞癌冷冻手术的重新评估。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND/AIMS: Liquid nitrogen spray freezing has been successfully applied for basal cell carcinomas in the eyelid region, but is not yet in general use. The reasons for this were analysed and the development of a more reliable, safer cryosurgical technique aimed for. METHODS: New cryosurgical apparatus, contact probes with increased freezing power, and a special application technique were developed and clinically tested in a consecutive series of 221 patients with primary basal cell carcinomas of the lid region. Special efforts yielded follow up reports of 220 out of the 221 patients. RESULTS: Experimental measurements and clinical results demonstrated that this cryosurgical technique was at least as effective as spray freezing, with lower risks. The rate of recurrent tumours in patients followed up for 5 years or longer was 5.1% (surgeons first result) respectively 0.6% (result after optimised second cryosurgery). The figures were 6.8%, respectively max 2.7%, when including all patients, independent of follow up time. CONCLUSION: Traditional surgery and histopathology, still used at numerous places, resulted in higher recurrence rates despite extended loss of healthy eyelid tissues and should be abandoned. Micrographic surgery is considered mandatory to save more of the healthy structures and to obtain lower recurrence rates. Cost and time require worldwide restriction of micrographic surgery to selected cases. Updated cryosurgery provides a low cost option to micrographic surgery and results in preservation of eyelid structures and lacrimal pathways, tarsal plate, lid margin. It provides excellent cosmetic results. Thus, primary basal cell carcinomas in the eyelid region of suitable size and location should receive updated cryosurgery, and tumours beyond its range micrographic surgery.
机译:背景/目的:液氮喷雾冷冻已成功应用于眼睑区域的基底细胞癌,但尚未广泛使用。分析了其原因,并针对此技术开发了一种更可靠,更安全的冷冻外科技术。方法:开发了新的冷冻手术设备,具有更高冷冻能力的接触探针以及一种特殊的应用技术,并在一系列连续的221例眼睑区域原发性基底细胞癌患者中进行了临床测试。经过特殊的努力,在221名患者中有220名获得了随访报告。结果:实验测量和临床结果表明,这种冷冻手术技术至少与喷雾冷冻一样有效,风险较低。随访5年或更长时间的患者中,复发性肿瘤的发生率分别为5.1%(外科医生第一个结果)和0.6%(经过优化的第二次冷冻手术后的结果)。当包括所有患者时,该数字分别为6.8%和最大2.7%,与随访时间无关。结论:尽管健康的眼睑组织长期丢失,但仍在许多地方使用的传统手术和组织病理学导致较高的复发率,应予以放弃。显微外科手术被认为是强制性的,以节省更多的健康结构并降低复发率。成本和时间要求显微摄影手术在全球范围内仅限于特定病例。更新的冷冻手术为显微外科手术提供了一种低成本的选择,并能保留眼睑结构和泪道,睑板,眼睑边缘。它提供了出色的美容效果。因此,在适当大小和位置的眼睑区域的原发性基底细胞癌应接受更新的冷冻手术,并且肿瘤应超出显微外科手术的范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号